Instil Bio, Inc. Share Price

Instil Bio, Inc. Share Price

NASDAQ: TIL | Micro Cap
$6.96
+$0.08 (1.09%) Last updated on 30 Oct, 2026 | 00:05 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Instil Bio, Inc. Stock Performance

Open
$7.00
Prev. Close
$6.88
Circuit Range
N/A
Day Range
$6.89 - $7.00
Year Range
$5.68 - $18.41
Volume
1,835
Average Traded
$6.99

Instil Bio, Inc. Share Price Today

As of 30 October 2026, Instil Bio, Inc.'s share price is $6.96. The stock opened at $7.00, compared to its previous close of $6.88. During today's trading session, Instil Bio, Inc.'s share price traded between $6.89 and $7.00, with an average price of $6.95. Over the past 52 weeks, the stock has recorded a high of $18.41 and a low of $5.68. In terms of performance, Instil Bio, Inc.'s share price has declined by 13.48% over the last six months and is down 60.28% on a year-on-year basis.

Instil Bio, Inc. Share Price Chart

Line chart of the Instil Bio, Inc. price trend over the selected period. The price rose overall, ranging from 6.89 to 7.00, ending at 6.96.
$6.89$7.00
L
Show Current Price
H

Instil Bio, Inc. Stock Fundamentals & Key Indicators

Market Cap
$46.38M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.26
Revenue (TTM)
$0.00
Return On Equity (TTM)
-20.57%
Profit Margin
N/A
Debt to Equity
0.79
Quarterly Earnings Growth YoY
68.36%

Instil Bio, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$2.24N/A$0.00$0.00
Net Profit-$13.59N/A-$4.20-$4.30
Net Profit Margin-606.70%N/AN/AN/A
Income ChangeN/AN/AN/A-2.38%

Instil Bio, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$223.18-$156.09-$74.14-$71.37
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A30.06%52.50%3.74%

About Instil Bio, Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Instil Bio, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$7.26
$6.89
-4.70%
Sep 2026
$7.62
$7.23
-1.57%
Aug 2026
$7.21
$7.34
+3.16%
Jul 2026
$7.72
$7.12
-6.44%
Jun 2026
$8.08
$7.61
-6.40%
May 2026
$8.19
$8.13
+1.13%
Apr 2026
$8.06
$8.04
-3.14%
Mar 2026
$8.41
$8.30
-6.85%
Feb 2026
$7.28
$8.91
+25.85%
Jan 2026
$11.45
$7.08
-31.86%
Dec 2025
$11.66
$10.39
-13.49%
Nov 2025
$17.02
$12.01
-31.41%

TIL Share Price FAQs